Are peptides legal in Pennsylvania?

Can a Pennsylvania resident get peptides by telehealth?

Act 42 of 2024 (Senate Bill 739, signed July 2024) is Pennsylvania's first comprehensive telemedicine statute. It defines telemedicine to include synchronous and asynchronous (store-and-forward) technology, authorizes any Pennsylvania-licensed health care practitioner to provide telemedicine within the practitioner's scope of practice, requires the same standard of care as in-person practice, and requires insurers to cover telemedicine services. The Act allows a practitioner to prescribe from a telemedicine encounter, subject to the practitioner's licensing board regulations and federal law on controlled substances. Before Act 42, Pennsylvania had no telemedicine statute and boards relied on general practice standards. The prescriber must hold a Pennsylvania license (or an Interstate Medical Licensure Compact license issued through the Pennsylvania State Board of Medicine). None of the peptides in this database are controlled substances, so no additional in-person requirement applies. [2] [3] [12]

How does the Pennsylvania pharmacy board treat compounding?

The State Board of Pharmacy licenses pharmacies under the Pharmacy Act (63 P.S. section 390-1 and following) and regulates practice through 49 Pa. Code chapter 27. The compounding rules at 49 Pa. Code sections 27.601 to 27.606 (effective June 22, 2019) require sterile and non-sterile compounding to follow section 503A of the federal Food, Drug, and Cosmetic Act, its regulations, and the current USP compounding chapters; section 27.602 bars pharmacists from compounding drugs FDA has withdrawn for safety or effectiveness, essentially copies of commercially available drugs except as 503A allows, and drugs FDA has identified as not compoundable. Pennsylvania has not adopted a separate list of compoundable bulk substances, so a peptide's eligibility follows the federal 503A test (approved drug component, USP or NF monograph, or FDA 503A bulks list). Section 4.1 of the Pharmacy Act (63 P.S. section 390-4.1, added in 2015) requires a nonresident pharmacy to register with the Board every two years, hold a valid home-state license, submit its most recent home-state or national inspection report, and provide a toll-free pharmacist line, and it bars shipping legend drugs into Pennsylvania without that certificate of registration. The Board's license verification confirms registration. [1] [4] [5] [7]

Can you get compounded GLP-1s in Pennsylvania?

Telehealth GLP-1 patients should confirm the dispensing pharmacy holds a Pennsylvania pharmacy permit or nonresident pharmacy registration. [1] [10]

Prices by channel: semaglutide cost, tirzepatide cost.

Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.

What is the legal access path in Pennsylvania?

Find a provider in Pennsylvania

• Compounding pharmacies in Pennsylvania
• Clinics in Pennsylvania
• Telehealth providers in Pennsylvania

Is it legal to buy research peptides in Pennsylvania?

The Pennsylvania Pharmacy Act restricts dispensing of prescription drugs to licensed pharmacies, and the Controlled Substance, Drug, Device and Cosmetic Act (35 P.S. section 780-101 and following) prohibits the sale of adulterated, misbranded, or unapproved new drugs in the Commonwealth. [4] [6] [11]

Peptide-specific notes for Pennsylvania

No peptide-specific rule identified for this jurisdiction. The general compounding and telehealth rules above apply, and the federal record covers semaglutide, tirzepatide, and BPC-157.

Frequently asked questions

Sources

Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, and federal FDA guidance.